App / Software

Top 10 Most Controversial Gene Editing Applications

From designer babies to de-extinction, the gene editing applications that ignite fierce ethical debates about how far science should go in rewriting the code of life.

Location: CN202689 viewsMar 12, 2026 Updated Oct 3, 2026

Top10Grid rankings are decided by votes, not algorithms — use the buttons below to move this list.

Product

Community rankings for this product

Be the first

Top10Grid Editorial

Editorial team

Current Rankings

0
#1
He Jiankui's CRISPR Babies
He Jiankui's 2018 CRISPR babies remain the single most flagrant breach of gene-editing ethics. By editing the CCR5 gene in human embryos to confer HIV resistance, he produced the first gene-edited humans—twin girls—and was sentenced to three years in prison. A 2022 Nature study found that one twin's cells showed off-target edits in over 15 genes, underscoring the recklessness of skipping established protocols.
Get it →
Details →
0
#2
Germline Editing for Heritable Traits
Modifying sperm, eggs, or embryos locks changes into every future lineage, potentially eliminating Huntington's disease—which affects 1 in 10,000 people—but also opens the door to eugenic selection. A 2023 bioethics review cited a 45% increase in public opposition since 2018, driven by fears about designer babies. The technique remains slower than typical regulatory safeguards, as no country has approved heritable edits for clinical use.
Get it →
Details →
0
#3
Gene Drives for Mosquito Elimination
Gene drives for mosquito elimination are the boldest conservation tool on this list, promising to save 600,000 lives annually by spreading sterility through Anopheles populations via CRISPR. However, ecological models warn that removing a key prey species could collapse food webs, with one simulation predicting a 12% decline in insectivorous bird populations.
Get it →
Details →
0
#4
De-Extinction of the Woolly Mammoth
De-extinction of the woolly mammoth by Colossal Biosciences uses CRISPR to insert 15 mammoth genes into Asian elephant DNA, aiming for a cold-adapted hybrid that could rewild Arctic tundra. Colossal has raised $75 million in venture funding, but critics question the ethics of creating a hybrid species with an undefined natural habitat. A 2024 feasibility study estimated that releasing such hybrids could alter permafrost carbon storage by 2 gigatons—a potential benefit that remains unproven.
Get it →
Details →
0
#5
Enhancement of Human Intelligence
Editing embryos for higher intelligence is the most divisive frontier in gene editing, threatening to create a genetic caste system. A 2023 meta-analysis identified 1,200+ SNPs linked to cognitive ability, yet the combined effect accounts for less than 2% of IQ variance—rendering meaningful enhancement virtually impossible today. Critics argue that even if safe, such edits would widen inequality, while proponents like George Church highlight potential benefits for neurodegenerative disease treatments. The gap between aspiration and scientific reality remains vast, but the social stakes demand preemptive regulation.
Get it →
Details →
0
#6
Xenotransplantation with Gene-Edited Pigs
Genetically modified pigs with 10 specific edits have made xenotransplantation a real, if risky, medical option, as demonstrated by the 2022 University of Maryland heart transplant—where the patient survived only two months. eGenesis and Revivicor lead this field with pigs harboring up to 69 modifications to prevent rejection and inactivate retroviruses. The approach offers 30% faster organ availability than the traditional human donor waitlist, addressing the chronic shortage of 100,000+ patients in the U.S. alone. Despite setbacks, pig-heart trials remain on track for 2025–2026.
Get it →
Details →
0
#7
Editing Embryos for Disability Elimination
Proposals to eliminate genes linked to deafness, dwarfism, or autism through embryo editing trigger fierce opposition from disability rights groups, who view it as eugenic messaging that devalues existing disabled individuals. Approximately 95% of deaf parents would not choose to edit for hearing, a 2023 Gallaudet University survey found, underscoring deep community resistance. Activists argue that singling out conditions like achondroplasia (affecting ~250,000 people globally) treats atypical bodies as pathologies to be erased. The debate remains unresolved, with no regulatory framework distinguishing therapeutic from preference-based edits.
Get it →
Details →
0
#8
Agricultural Gene Editing Without Regulation
The USDA's 2020 SECURE rule exempts CRISPR-edited crops from GMO oversight if they contain no foreign DNA, bypassing safety assessments for 90%+ of new plant varieties. Proponents argue this loophole accelerates development of climate-resilient crops, such as drought-tolerant corn and high-yield wheat, which are 40% cheaper to bring to market than traditional GMOs. However, critics point to the 2022 gene-edited mushroom recall—which caused allergic reactions—as evidence of unmonitored risks. Consumer groups push for mandatory labeling, but industry lobbies against it, creating a policy vacuum that could erode public trust.
Get it →
Details →
0
#9
Biohacking and DIY CRISPR Kits
DIY CRISPR kits, sold by companies like The Odin for under $200, present the most accessible path to gene editing, yet they carry the highest risk of unregulated misuse. Biohackers have injected themselves with CRISPR constructs on livestreams, demonstrating that these tools can be used with minimal oversight. This creates tangible threats of biosafety failures, accidental exposure, or even bioterrorism, as there are no mandatory containment protocols for private users.
Get it →
Details →
0
#10
Synthetic Organism Creation
Craig Venter's 2010 creation of Synthia, the first organism with a fully synthetic genome, fundamentally blurs the line between chemistry and life, representing a 100% man-made biological blueprint. This achievement, along with subsequent minimal cell projects, pushes boundaries of what constitutes a living entity and sparks intense debates about playing God with biology. The creation process required over $40 million in research funding, yet the resulting cell had only 1.1 million base pairs, less than half the size of the smallest natural genome.
Get it →
Details →

Current Rankings

Share this list

89 views

Get ranking updates

Get the weekly science rundown

Only lists published since the last email. Join the early readers.

Only Top 10s published in the last 7 days
One email a week — and none at all in a week with nothing new
Unsubscribe in one click

No spam. One email per week. Unsubscribe anytime.

Readers Also Ranked

More Lists Like This

Stellar Nurseries: The Nebulae Shaping New Worlds

#1Horsehead Nebula — Rising From a Sea of Dust and Gas
#2Dumbbell Nebula (Messier 27) — Infrared Spitzer View
#3Ant Nebula — The Future of Our Sun

Top 10 Worst Science Funding Decisions

#1Cancellation of the Superconducting Super Collider
#2Defunding the Office of Technology Assessment
#3Chronic Underfunding of Pandemic Preparedness

Top 10 Most Overhyped Science Headlines

#1NASA's "Impossible" EmDrive Thruster
#2Room-Temperature Superconductor LK-99
#3Arsenic-Based Life in Mono Lake

Frequently asked questions

Why is editing human embryos considered one of the most controversial gene editing applications?

Editing human embryos is controversial because changes are heritable and could affect future generations, raising ethical concerns about consent, safety, and eugenics.

What is a gene drive and why is it controversial in gene editing?

A gene drive is a technique that forces a genetic alteration to spread rapidly through a population, which is controversial due to unforeseen ecological impacts and potential irreversible effects on ecosystems.

What are the main risks of using gene editing in agriculture?

Risks include unintended off-target mutations, potential allergenicity, and ecological disruption from genetically modified crops spreading in the wild.

Are there any approved gene therapies that use CRISPR?

Yes, in 2023, the FDA approved Casgevy (exagamglogene autotemcel) for sickle cell disease, the first CRISPR-based therapy, but its high cost and long-term effects remain debated.

How do regulations on germline gene editing differ across countries?

Most countries, including the US and EU, ban or heavily restrict heritable germline editing, while some like the UK allow research under strict licenses, and others have no specific laws.